Xebra Brands Receives Second CBD Product Approval by COFEPRIS

Xebra Brands Ltd., a leading cannabis company, announced another milestone with its second CBD product authorization in Mexico, granted by the Federal Commission for the Protection against Sanitary Risk (COFEPRIS). The company aims to cater to the increasing demand for high-quality CBD products among Mexican consumers.

The approval encompasses the importation, launch, and sale of a new 250mg Tincture, following the success of their previously approved Tangerine Flavor CBD Tincture. These developments reflect Xebra’s continuous commitment to innovation, quality, and compliance in the CBD market.

Rodrigo Gallardo, Interim CEO of Xebra Brands, expressed his enthusiasm about the new authorization and its significance in strengthening the trust placed in the company by regulatory authorities. He highlighted their ongoing mission to enhance access to premium CBD products across Mexico.

The newly approved 250mg Tincture maintains the same high standards of quality and purity as Xebra's other products, all thoroughly tested for potency and consistency by third-party laboratories. This assures Mexican consumers access to dependable CBD options. With this approval, Xebra solidifies its reputation as a leader in Mexico’s CBD industry, aligning with its broader goal of promoting natural wellness solutions.